How Can We Target Pulmonary Inflammation in Cystic Fibrosis?

Por Greene, Catherine M.
Publicado em 2010

MicroRNA Expression in Cystic Fibrosis Airway Epithelium

Por Greene, Catherine M.
Publicado em 2013

Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease

Por Jundi, Karim, Greene, Catherine M.
Publicado no Biomolecules (2015)

Best of Milan 2017—ERS Lung Science Conference session “Lung tissue repair and remodeling in chronic lung diseases: mechanisms and therapeutic approaches”

Por Bartel, Sabine, Greene, Catherine M.
Publicado no J Thorac Dis (2017)

Proteases and antiproteases in chronic neutrophilic lung disease – relevance to drug discovery

Por Greene, Catherine M, McElvaney, Noel G
Publicado em 2009

Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response

Por Greene, Catherine M, McElvaney, Noel G
Publicado em 2010

MicroRNA Dysregulation in Cystic Fibrosis

Por McKiernan, Paul J., Greene, Catherine M.
Publicado no Mediators Inflamm (2015)

Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?

Por Greene, Catherine M., Chhabra, Roohi, McElvaney, Noel G.
Publicado em 2013

MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled

Por Greene, Catherine M, Varley, Robert B, Lawless, Matthew W
Publicado em 2013

Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency

Por McLean, Caitriona, Greene, Catherine M, McElvaney, Noel G
Publicado em 2009

MicroRNAs in inflammatory lung disease - master regulators or target practice?

Por Oglesby, Irene K, McElvaney, Noel G, Greene, Catherine M
Publicado em 2010

Pulmonary Proteases in the Cystic Fibrosis Lung Induce Interleukin 8 Expression from Bronchial Epithelial Cells via a Heme/Meprin/Epidermal Growth Factor Receptor/Toll-like Recepto...

Por Cosgrove, Sonya, Chotirmall, Sanjay H., Greene, Catherine M., McElvaney, Noel G.
Publicado em 2011

Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology

Por McKiernan, Paul J, Cunningham, Orla, Greene, Catherine M, Cryan, Sally-Ann
Publicado em 2013

Potential of Host Defense Peptide Prodrugs as Neutrophil Elastase-Dependent Anti-Infective Agents for Cystic Fibrosis

Por Forde, Éanna, Humphreys, Hilary, Greene, Catherine M., Fitzgerald-Hughes, Deirdre, Devocelle, Marc
Publicado em 2014

Secretory Leucoprotease Inhibitor Impairs Toll-Like Receptor 2- and 4-Mediated Responses in Monocytic Cells

Por Greene, Catherine M., McElvaney, Noel G., O'Neill, Shane J., Taggart, Clifford C.
Publicado em 2004

Quantification and Evaluation of the Role of Antielastin Autoantibodies in the Emphysematous Lung

Por Low, Teck Boon, Greene, Catherine M., O'Neill, Shane J., McElvaney, Noel G.
Publicado em 2011

Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB

Por Hassan, Tidi, de Santi, Chiara, Mooney, Catherine, McElvaney, Noel G., Greene, Catherine M.
Publicado no Sci Rep (2017)

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity

Por McGarry, Niamh, Greene, Catherine M., McElvaney, Noel G., Weldon, Sinéad, Taggart, Clifford C.
Publicado no J Immunol Res (2015)

miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6

Por Oglesby, Irene K, Agrawal, Raman, Mall, Marcus A, McElvaney, Noel G, Greene, Catherine M
Publicado no Mol Cell Pediatr (2015)

Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant α(1)-Antitrypsin Deficiency

Por Kelly, Emer, Greene, Catherine M., Carroll, Tomás P., McElvaney, Noel G., O'Neill, Shane J.
Publicado em 2009